Trials / Unknown
UnknownNCT03810482
Pedometers and Walking Tests for Pulmonary Hypertension Patients
Pedometers and Walking Tests for Pulmonary Hypertension Patients: a First, Prospective Psychology and Concordance Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Concordance between walking tests and pedometer data may seem like a logical outcome for pulmonary hypertension (PH) patients. However, many individuals have discordant results: results much worse or better during an in-hospital walking test as compared to real life activity. The primary objective of this study is: to determine variables associated with discordance between the distance walked during an in-hospital 6-minute walking test (6MWT) and the average distance travelled per day (observed over a period of 28 days (2 × 14 days) using a pedometer) among PH patients.
Detailed description
Secondarily, the discordance between 6MWT results versus total pedometer recorded distance and versus maximum daily pedometer-recorded distance will be similarly studied. The aim of the study is also to search for variables associated with progression free survival. The relationships between pedometer data and self-reported dyspnea variation will be studied. Factorial analysis may be used to study the overall view of variable correlations and patient similarity/dissimilarity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pedometer | A pedometer will be worn by the patient at home for days 1 to 14 and 60 to 74. |
| OTHER | 6 minute walking test | Performed according to current recommendations during routine visits (baseline and \~90 days for the purposes of this study). |
Timeline
- Start date
- 2019-03-21
- Primary completion
- 2024-06-21
- Completion
- 2024-06-21
- First posted
- 2019-01-18
- Last updated
- 2023-09-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03810482. Inclusion in this directory is not an endorsement.